Contacts

Venture Life Group PLC +44 (0) 1344 742870

Jerry Randall, Chief Executive Officer
Adrian Crockett, Chief Financial Officer

Northland Capital Partners Limited +44 (0) 20 3861 6625
(Nominated Adviser and Joint Broker)

Matthew Johnson / Edward Hutton (Corporate Finance)
Vadim Alexandre (Corporate Broking)

Cenkos Securities PLC (Joint Broker) +44 (0) 20 7397 8900

Camilla Hume / Mark Connelly (Corporate Finance)
Michael F Johnson / Russell Kerr (Sales)

Turner Pope Investments (TPI) Ltd (Joint Broker) +44 (0) 20 3621 4120

James Pope / Ben Turner

Walbrook PR + 44 (0) 20 7933 8780

Anna Dunphy venturelife@walbrookpr.com

+44 (0) 7876 741 001

About Venture Life (www.venture-life.com)

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product portfolio includes some key products such as the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, medical devices for women's intimate healthcare and haemorrhoids and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.

Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

Attachments

  • Original document
  • Permalink

Disclaimer

Venture Life Group plc published this content on 20 July 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 20 July 2018 17:37:04 UTC